Evidence map›Paper›PMID 34228749›Full record

Observational studyPloS one2021

Position effects of 22q13 rearrangements on candidate genes in Phelan-McDermid syndrome.

Sujata Srikanth, Lavanya Jain, Cinthya Zepeda-Mendoza, Lauren Cascio, Kelly Jones, Rini Pauly, Barb DuPont, Curtis Rogers, Sara Sarasua, Katy Phelan and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Updated consensus guidelines on the management of Phelan-McDermid syndrome.American journal of medical genetics. Part A · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Sujata SrikanthGreenwood Genetic Center, Greenwood, SC, United States of America.
Lavanya JainSchool of Nursing, Healthcare Genetics Program, Clemson University, Clemson, SC, United States of America.
Cinthya Zepeda-MendozaDepartment of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, United States of America.
Lauren CascioGreenwood Genetic Center, Greenwood, SC, United States of America.
Kelly JonesGreenwood Genetic Center, Greenwood, SC, United States of America.
Rini PaulyGreenwood Genetic Center, Greenwood, SC, United States of America.
Barb DuPontGreenwood Genetic Center, Greenwood, SC, United States of America.
Curtis RogersGreenwood Genetic Center, Greenwood, SC, United States of America.
Sara SarasuaSchool of Nursing, Healthcare Genetics Program, Clemson University, Clemson, SC, United States of America.
Katy PhelanGenetics Laboratory, Florida Cancer Specialists and Research Institute, Fort Myers, FL, United States of America.
Cynthia MortonDepartment of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, United States of America.
Luigi BoccutoGreenwood Genetic Center, Greenwood, SC, United States of America.ORCID 0000-0003-2017-4270
Greenwood Genetic Center · USClemson University · USBrigham and Women's Hospital · USBroad Institute · USFlorida Cancer Specialists & Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phelan-McDermid syndrome (PMS) is a multi-system disorder characterized by significant variability in clinical presentation. The genetic etiology is also variable with differing sizes of deletions in the chromosome 22q13 region and types of genetic abnormalities (e.g., terminal or interstitial deletions, translocations, ring chromosomes, or SHANK3 variants). Position effects have been shown to affect gene expression and function and play a role in the clinical presentation of various genetic conditions. This study employed a topologically associating domain (TAD) analysis approach to investigate position effects of chromosomal rearrangements on selected candidate genes mapped to 22q13 in 81 individuals with PMS. Data collected were correlated with clinical information from these individuals and with expression and metabolic profiles of lymphoblastoid cells from selected cases. The data confirmed TAD predictions for genes encompassed in the deletions and the clinical and molecular data indicated clear differences among individuals with different 22q13 deletion sizes. The results of the study indicate a positive correlation between deletion size and phenotype severity in PMS and provide evidence of the contribution of other genes to the clinical variability in this developmental disorder by reduced gene expression and altered metabolomics.

Indexed as

Gene RearrangementAdolescentChildChild, PreschoolChromosome DeletionChromosome DisordersChromosomes, Human, Pair 22Cohort StudiesFemaleGenetic VariationHumansMale

Identifiers

PMID34228749
PMCPMC8259982
OpenAlexW3178060416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.